EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Corticostriatal glutamate‐mediated dynamic therapeutic efficacy of electroacupuncture in a parkinsonian rat model

Xinxin Jiang, Min Sun, Yitong Yan, Yanhua Wang, Xinyu Fan, Jing Wei, Ke Wang, Peirong Liang, Zirui Wang, Jihan Wang, Xiaomin Wang, Jun Jia iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.70117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Xinxin Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Science, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Electroacupuncture, Disease Models, Animal, Glutamic Acid, Rats, Sprague-Dawley. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Motor impairments are the defining cardinal features of Parkinson's disease (PD), resulting from malfunction of the cortico‐basal ganglia circuit. Clinical data have demonstrated that electroacupuncture (EA) stimulation may benefit motor symptoms in PD without adverse effects. However, the specific effects of EA on PD and the underlying mechanisms remain largely unclear.

Methods

This study investigated the effects of EA stimulation during and after 100 Hz application in a rat model of PD created by unilateral injection of 6‐hydroxydopamine (6‐OHDA). To establish optimal treatment parameters of EA, motor behaviours were dynamically assessed using open field and rotarod tests. Additionally, we evaluated corticostriatal spine plasticity using immunoelectron microscopy and measured the levels of dopaminergic and glutamatergic neurotransmitters through microdialysis, in vivo electrochemistry and high‐performance liquid chromatography. Neural activity dynamics were recorded by measuring local field potentials in both the motor cortex and the striatum. Furthermore, chemogenetic techniques were employed to manipulate corticostriatal glutamatergic neurons and clarify the mechanisms that contribute to the therapeutic benefits of EA in the PD rat model.

Results

Chronic EA stimulation resulted in a gradual and long‐lasting alleviation of motor symptoms, independent of nigrostriatal dopamine (DA) restoration. Notably, EA stimulation modulated corticostriatal spine plasticity and reduced excessive glutamate transmission in PD model rats. Moreover, EA effectively inhibited aberrant corticostriatal synchronised high‐beta (25–40 Hz) oscillations, which serves as a pathological biomarker of PD. Conversely, chronic chemogenetic activation of corticostriatal glutamatergic neurons hindered these positive outcomes of EA treatment in PD model rats.

Conclusions

This study sheds light on the temporal dynamics and optimal parameters of EA treatment in PD. It emphasises the significance of inhibiting corticostriatal glutamate transmission in EA's therapeutic benefits for PD. Targeting glutamatergic neurons with EA holds promise as a non‐dopaminergic intervention for managing motor symptoms and abnormal neural activity with PD. Key points EA commonly protects dopaminergic neuronsby reducing neuroinflammation, oxidative stress, and apoptosis. New findings reveal that EA alleviates motor symptoms in a parkinsonian rat model without restoring striatal dopamine levels. EA effectively suppresses excessiveglutamate transmission and high‐beta synchronization, contributing to motorsymptom relief. Activation of corticostriatalglutamatergic projections may hinder the efficacy of EA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectroacupunctureDisease Models, AnimalGlutamic AcidRats, Sprague-DawleyAnimalsRatsMaleCorpus StriatumParkinson DiseaseMotor Cortex

Stichwörter der Autor:innen

Parkinson's diseasebeta oscillatory synchronycorticostriatal glutamate transmissionelectroacupuncture stimulation

Substanzen

Glutamic Acid

Autor:innen und Institutionen

  • Department of Physiology and Pathophysiology, School of Basic Medical Science, Capital Medical University, Beijing, China.
  • Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • School of Biomedical Engineering, Capital Medical University, Beijing, China.

ORCID-Profile: Jun Jia

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Jiang, X., Sun, M., Yan, Y., Wang, Y., Fan, X., Wei, J., Wang, K., Liang, P., Wang, Z., Wang, J., Wang, X., & Jia, J. (2024). Corticostriatal glutamate‐mediated dynamic therapeutic efficacy of electroacupuncture in a parkinsonian rat model. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70117

Vancouver

Jiang X, Sun M, Yan Y, Wang Y, Fan X, Wei J, et al. Corticostriatal glutamate‐mediated dynamic therapeutic efficacy of electroacupuncture in a parkinsonian rat model. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.70117

BibTeX
@article{Jiang2024,
  author = {Jiang, Xinxin and Sun, Min and Yan, Yitong and Wang, Yanhua and Fan, Xinyu and Wei, Jing and Wang, Ke and Liang, Peirong and Wang, Zirui and Wang, Jihan and Wang, Xiaomin and Jia, Jun},
  title = {Corticostriatal glutamate‐mediated dynamic therapeutic efficacy of electroacupuncture in a parkinsonian rat model},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.70117}
}
Kostenlos starten →